Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Naturex SA

www.naturex.com

Latest From Alpharma LLC

Perrigo Trims Workforce, Ships Tysabri License, Stays European Course

The firm is reducing its non-production workforce by 750, a decision made after three representatives of disgruntled investor Starboard Value joined its board. Perrigo charts a course of recovery for its struggling international consumer health business, but some analysts are convinced it took a wrong turn with its 2015 investment in European OTC drug and nutritional product businesses and brands.

Europe United States

Norway’s Xellia Pharma Acquired By Novo A/S In $700 Million Buyout

3i sells Nordic antibacterial manufacturer Xellia Pharmaceuticals, which has plans to develop novel antibiotics, new formulations and new bulk generics.

BioPharmaceutical Denmark

Watson Becomes Actavis: Name Change To Reflect Greater International Focus

Watson’s merger with Actavis will create the world’s third-largest generic drug company, to be known as Actavis, with significant ex-U.S. market share, especially in the U.K., Nordic countries and Russia.

BioPharmaceutical North America

Watson/Actavis: Name Is Just One Of Many Changes Resulting From Merger Completion

With the Actavis deal finalized, Watson achieves its long-sought goal of becoming a major international player in generics, and announces a new global management team to undertake the critical component: execution.

BioPharmaceutical North America
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Nutraceuticals
  • Therapeutic Areas
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • France
  • Parent & Subsidiaries
  • Naturex SA
  • Senior Management
  • Thierry Lambert, CEO
    Marc Roller, Scientific Dir.
  • Contact Info
  • Naturex SA
    Phone: 4 90 23 96 89
    Site d'Agroparc - BP 1218
    84911 Avignon,
    France
Advertisement
Advertisement
UsernamePublicRestriction

Register